Abstract:Molecular medicine is an emerging field focused on understanding the molecular basis of diseases and translating this information into strategies for diagnosis and therapy. This approach could lead to personalized medical treatments. Currently, our ability to understand human diseases at the molecular level is limited by the lack of molecular tools to identify and characterize the distinct molecular features of the disease state, especially for diseases such as cancer. Among the new tools being developed by researchers including chemists, engineers, and other scientists is a new class of nucleic acid probes called aptamers, which are ssDNA/RNA molecules selected to target a wide range of molecules and even cells. In this Account, we will focus on the use of aptamers, generated from cell-based selections, as a novel molecular tool for cancer research. Cancers originate from mutations of human genes. These genetic alterations result in molecular changes to diseased cells, which, in turn, lead to changes in cell morphology and physiology. For decades, clinicians have diagnosed cancers primarily based on the morphology of tumor cells or tissues. However, this method does not always give an accurate diagnosis and does not allow clinicians to effectively assess the complex molecular alterations that are predictive of cancer progression. As genomics and proteomics do not yet allow a full access to this molecular knowledge, aptamer probes represent one effective and practical avenue toward this goal. One special feature of aptamers is that we can isolate them by selection against cancer cells without prior knowledge of the number and arrangement of proteins on the cellular surface. These probes can identify molecular differences between normal and tumor cells and can discriminate among tumor cells of different classifications, at different disease stages, or from different patients. This Account summarizes our recent efforts to develop aptamers through cell-SELEX for the study of cancer and apply those aptamers in cancer diagnosis and therapy. We first discuss how we select aptamers against live cancer cells. We then describe uses of these aptamers. Aptamers can serve as agents for molecular profiling of specific cancer types. They can also be used to modify therapeutic reagents to develop targeted cancer therapies. Aptamers are also aiding the discovery of new cancer biomarkers through the recognition of membrane protein targets. Importantly, we demonstrate how molecular assemblies can integrate the properties of aptamers and, for example, nanoparticles or microfluidic devices, to improve cancer cell enrichment, detection and therapy.

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule

Aptamers: an Emerging Navigation Tool of Therapeutic Agents for Targeted Cancer Therapy

Novel Insights into the Role of Aptamers in the Fight Against Cancer.

Selection of DNA Aptamers Against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture.

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy

Aptamer‐Based Cancer Cell Analysis and Treatment

Biostable Aptamer Rings Conjugated for Targeting Two Biomarkers on Circulating Tumor Cells in Vivo with Great Precision

The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer

Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy.

Using live cells to generate aptamers for cancer study.

Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy

Aptamer-conjugated Nanomaterials for Specific Cancer Cell Recognition and Targeted Cancer Therapy.

A Cell-Based Single-Stranded DNA Aptamer Specifically Targets Gastric Cancer

Aptamers Selected By Cell-Selex For Application In Cancer Studies

Aptamers: Versatile Molecular Recognition Probes for Cancer Detection.

Abstract 367: Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection

Nucleic Acid Aptamers: an Emerging Frontier in Cancer Therapy

Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach

Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer

Dna Aptamer-Micelle As an Efficient Detection/Delivery Vehicle Toward Cancer Cells